Table 2. Clinicopathologic details of patients with EGFR-mutated lung adenocarcinoma.
Case | Age, years | Sex | Smoking history | Pack-years | Tissue type | TNM | Stage | BALF EGFR genotype | Tissue EGFR genotype |
---|---|---|---|---|---|---|---|---|---|
1 | 70 | Male | NS | 0 | S | T1bN1M1a | IV | Exon 19 Del | Exon 19 Del |
2 | 73 | Female | NS | 0 | B | T2bN3M1b | IV | Exon 21 L858R | Exon 21 L858R |
3 | 82 | Female | NS | 0 | B | T4N0MM0 | IIIA | Exon 19 Del | Exon 19 Del |
4 | 72 | Female | NS | 0 | S | T2aN0M1a | IV | Exon 19 Del | Exon 19 Del |
5 | 72 | Male | CS | 12.4 | S | T1aN2M0 | IIIA | Exon 19 Del | Exon 19 Del |
6 | 65 | Male | CS | 25 | B | T3N3M0 | IIIB | T790M | WT |
7 | 61 | Female | NS | 0 | B | T3N3M0 | IIIB | Exon 21 L858R, Exon 20 S768I | Exon 21 L858R, Exon 20 S768I |
8 | 62 | Female | NS | 0 | B | T4N3M1b | IV | Exon 19 Del, T790M | Exon 19 Del |
9 | 65 | Male | NS | 0 | B | T4N2M1b | IV | Exon 19 Del | Exon 19 Del |
10 | 71 | Male | ES | 40 | S | T1bN0M0 | IA | Exon 19 Del | Exon 19 Del |
11 | 42 | Male | CS | 8 | B | T4N3M1b | IV | Exon 19 Del | Exon 19 Del |
12 | 65 | Female | NS | 0 | B | T1bN2M0 | IIIA | Exon 19 Del | Exon 19 Del |
13 | 59 | Female | NS | 0 | B | T2N2M1b | IV | Exon 19 Del | Exon 19 Del |
14 | 59 | Male | NS | 0 | B | T4N3M1b | IV | Exon 21 L858R | Exon 21 L858R |
15 | 78 | Female | NS | 0 | B | T2aN3M0 | IIIB | Exon 19 Del | Exon 19 Del, T790M |
16 | 76 | Female | NS | 0 | B | T2N3M1b | IV | Exon 19 Del | Exon 19 Del |
17 | 44 | Female | ES | 1 | B | T4N0M1b | IV | Exon 18 G719C, Exon 20 S768I | Exon 18 G719C, Exon 20 S768I |
18 | 88 | Male | CS | 60 | B | T4N3M1b | IV | Exon 21 L858R | Exon 21 L858R |
19 | 85 | Female | NS | 0 | B | T4N0M1a | IV | Exon 21 L858R | Exon 21 L858R |
20 | 53 | Female | NS | 0 | B | T1aN3M0 | IIIB | Exon 19 Del | Exon 19 Del |
NS, non-smoker; EX, ex-smoker; CS, current smoker; S, surgical tissue; B, biopsy tissue.